Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Korc

Showing results (91-100 of 203) with videos related to

Pageof 21
Sort By:
International Journal of Oncology|May 5, 2011
Insulin-like growth factor II activates mitogenic signaling in pancreatic cancer cells via IRS-1U Bergmann, H Funatomi, M Kornmann, et al.
The American Journal of Physiology|January 1, 1981
Insulin action in pancreatic acini from streptozotocin-treated rats. II. Binding of 125I-insulin to receptorsH Sankaran, Y Iwamoto, M Korc, et al.
Digestive Diseases and Sciences|September 1, 1990
Epidermal growth factor receptor overexpression and trisomy 7 in a case of Barrett's esophagusH Garewal, P Meltzer, J Trent, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 14, 2001
Soluble type II transforming growth factor-beta (TGF-beta) receptor inhibits TGF-beta signaling in COLO-357 pancreatic cancer cells in vitro and attenuates tumor formationM A Rowland-Goldsmith, H Maruyama, T Kusama, et al.
Cancer Research|October 15, 1993
Aberrant expression of type I fibroblast growth factor receptor in human pancreatic adenocarcinomasM S Kobrin, Y Yamanaka, H Friess, et al.
The American Journal of Physiology|January 1, 1981
Insulin action in pancreatic acini from streptozotocin-treated rats. I. Stimulation of protein synthesisM Korc, Y Iwamoto, H Sankaran, et al.
International Journal of Oncology|May 12, 2011
Increased mdm2 expression and immunoreactivity in human pancreatic ductal adenocarcinomaM Ebert, M Yokoyama, M Kobrin, et al.
The American Journal of Pathology|July 17, 1998
Characterization of keratinocyte growth factor and receptor expression in human pancreatic cancerT Ishiwata, H Friess, M W Büchler, et al.
Oncology|July 15, 1998
Increased cyclin D1 in human pancreatic cancer is associated with decreased postoperative survivalM Kornmann, T Ishiwata, J Itakura, et al.
Biochemical and Biophysical Research Communications|March 2, 1999
Smad6 suppresses TGF-beta-induced growth inhibition in COLO-357 pancreatic cancer cells and is overexpressed in pancreatic cancerJ Kleeff, H Maruyama, H Friess, et al.
Pageof 21

Showing results (91-100 of 203) with videos related to

Sort By:
Pageof 21
International Journal of Oncology|May 5, 2011
Insulin-like growth factor II activates mitogenic signaling in pancreatic cancer cells via IRS-1U Bergmann, H Funatomi, M Kornmann, et al.
The American Journal of Physiology|January 1, 1981
Insulin action in pancreatic acini from streptozotocin-treated rats. II. Binding of 125I-insulin to receptorsH Sankaran, Y Iwamoto, M Korc, et al.
Digestive Diseases and Sciences|September 1, 1990
Epidermal growth factor receptor overexpression and trisomy 7 in a case of Barrett's esophagusH Garewal, P Meltzer, J Trent, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 14, 2001
Soluble type II transforming growth factor-beta (TGF-beta) receptor inhibits TGF-beta signaling in COLO-357 pancreatic cancer cells in vitro and attenuates tumor formationM A Rowland-Goldsmith, H Maruyama, T Kusama, et al.
Cancer Research|October 15, 1993
Aberrant expression of type I fibroblast growth factor receptor in human pancreatic adenocarcinomasM S Kobrin, Y Yamanaka, H Friess, et al.
The American Journal of Physiology|January 1, 1981
Insulin action in pancreatic acini from streptozotocin-treated rats. I. Stimulation of protein synthesisM Korc, Y Iwamoto, H Sankaran, et al.
International Journal of Oncology|May 12, 2011
Increased mdm2 expression and immunoreactivity in human pancreatic ductal adenocarcinomaM Ebert, M Yokoyama, M Kobrin, et al.
The American Journal of Pathology|July 17, 1998
Characterization of keratinocyte growth factor and receptor expression in human pancreatic cancerT Ishiwata, H Friess, M W Büchler, et al.
Oncology|July 15, 1998
Increased cyclin D1 in human pancreatic cancer is associated with decreased postoperative survivalM Kornmann, T Ishiwata, J Itakura, et al.
Biochemical and Biophysical Research Communications|March 2, 1999
Smad6 suppresses TGF-beta-induced growth inhibition in COLO-357 pancreatic cancer cells and is overexpressed in pancreatic cancerJ Kleeff, H Maruyama, H Friess, et al.
Pageof 21